These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosis. Salvisberg C; Tajouri N; Hainard A; Burkhard PR; Lalive PH; Turck N Proteomics Clin Appl; 2014 Apr; 8(3-4):185-94. PubMed ID: 24488530 [TBL] [Abstract][Full Text] [Related]
26. Intact Protein Analysis by LC-MS for Characterizing Biomarkers in Cerebrospinal Fluid. Vialaret J; Lehmann S; Hirtz C Methods Mol Biol; 2019; 1959():163-172. PubMed ID: 30852822 [TBL] [Abstract][Full Text] [Related]
27. Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis. Hinsinger G; Galéotti N; Nabholz N; Urbach S; Rigau V; Demattei C; Lehmann S; Camu W; Labauge P; Castelnovo G; Brassat D; Loussouarn D; Salou M; Laplaud D; Casez O; Bockaert J; Marin P; Thouvenot E Mult Scler; 2015 Sep; 21(10):1251-61. PubMed ID: 25698171 [TBL] [Abstract][Full Text] [Related]
28. Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM. Kroksveen AC; Aasebø E; Vethe H; Van Pesch V; Franciotta D; Teunissen CE; Ulvik RJ; Vedeler C; Myhr KM; Barsnes H; Berven FS J Proteomics; 2013 Jan; 78():312-25. PubMed ID: 23059536 [TBL] [Abstract][Full Text] [Related]
29. Application of an Aptamer-Based Proteomics Assay (SOMAscan™) in Rat Cerebrospinal Fluid. Simats A; Ramiro L; Montaner J; García-Berrocoso T Methods Mol Biol; 2019; 2044():221-231. PubMed ID: 31432415 [TBL] [Abstract][Full Text] [Related]
30. Identification of biomarkers in cerebrospinal fluid and serum of multiple sclerosis patients by immunoproteomics approach. Colomba P; Fontana S; Salemi G; Barranca M; Lo Sicco C; Mazzola MA; Ragonese P; Savettieri G; De Leo G; Alessandro R; Duro G Int J Mol Sci; 2014 Dec; 15(12):23269-82. PubMed ID: 25517032 [TBL] [Abstract][Full Text] [Related]
31. Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis. Avsar T; Korkmaz D; Tütüncü M; Demirci NO; Saip S; Kamasak M; Siva A; Turanli ET Mult Scler; 2012 Aug; 18(8):1081-91. PubMed ID: 22252467 [TBL] [Abstract][Full Text] [Related]
32. A Chronic Fatigue Syndrome - related proteome in human cerebrospinal fluid. Baraniuk JN; Casado B; Maibach H; Clauw DJ; Pannell LK; Hess S S BMC Neurol; 2005 Dec; 5():22. PubMed ID: 16321154 [TBL] [Abstract][Full Text] [Related]
33. Cerebrospinal fluid proteome profile in multiple sclerosis. Lehmensiek V; Süssmuth SD; Tauscher G; Brettschneider J; Felk S; Gillardon F; Tumani H Mult Scler; 2007 Aug; 13(7):840-9. PubMed ID: 17881397 [TBL] [Abstract][Full Text] [Related]
34. Proteomic signatures of neuroinflammation in Alzheimer's disease, multiple sclerosis and ischemic stroke. Thygesen C; Larsen MR; Finsen B Expert Rev Proteomics; 2019 Jul; 16(7):601-611. PubMed ID: 31220951 [No Abstract] [Full Text] [Related]
35. Vitamin D Binding Protein Isoforms and Apolipoprotein E in Cerebrospinal Fluid as Prognostic Biomarkers of Multiple Sclerosis. Perga S; Giuliano Albo A; Lis K; Minari N; Falvo S; Marnetto F; Caldano M; Reviglione R; Berchialla P; Capobianco MA; Malentacchi M; Corpillo D; Bertolotto A PLoS One; 2015; 10(6):e0129291. PubMed ID: 26046356 [TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal fluid amyloid precursor protein as a potential biomarker of fatigue in multiple sclerosis: A pilot study. Johansson K; Wasling P; Novakova L; Sjödin S; Brinkmalm A; Brinkmalm G; Blennow K; Zetterberg H; Axelsson M Mult Scler Relat Disord; 2022 Jul; 63():103846. PubMed ID: 35550479 [TBL] [Abstract][Full Text] [Related]
37. Comprehensive phenotyping in multiple sclerosis: discovery based proteomics and the current understanding of putative biomarkers. O'Connor KC; Roy SM; Becker CH; Hafler DA; Kantor AB Dis Markers; 2006; 22(4):213-25. PubMed ID: 17124343 [TBL] [Abstract][Full Text] [Related]
38. Profiling and identification of cerebrospinal fluid proteins in a rat EAE model of multiple sclerosis. Rosenling T; Stoop MP; Attali A; van Aken H; Suidgeest E; Christin C; Stingl C; Suits F; Horvatovich P; Hintzen RQ; Tuinstra T; Bischoff R; Luider TM J Proteome Res; 2012 Apr; 11(4):2048-60. PubMed ID: 22320401 [TBL] [Abstract][Full Text] [Related]
39. Ten years of proteomics in multiple sclerosis. Farias AS; Pradella F; Schmitt A; Santos LM; Martins-de-Souza D Proteomics; 2014 Mar; 14(4-5):467-80. PubMed ID: 24339438 [TBL] [Abstract][Full Text] [Related]
40. [Fatigue in patients with multiple sclerosis--pathogenesis, clinical picture, diagnosis and treatment]. Patejdl R; Penner IK; Noack TK; Zettl UK Fortschr Neurol Psychiatr; 2015 Apr; 83(4):211-20. PubMed ID: 25893494 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]